This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Rosalind Franklin University of Medicine and Science, Sanford-Burnham Medical Research Institute, Sanford Burnham Prebys Medical Discovery Institute. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- North Chicago, IL (US) (2015 - 2018)
- La Jolla, CA (US) (2016 - 2019)
Company Filing History:
3 out of 50 
3 out of 99 
1 out of 99 
Years Active: 2015-2019
Sure, thank you for providing the information about inventor Russell Dahl. Here is the article based on the data you provided:
Title: Innovator Spotlight: Russell Dahl - Pioneer in Neuronal Calcium Dyshomeostasis
Introduction: Russell Dahl, a leading inventor based in North Chicago, IL, has made significant contributions in the field of stabilizing ryanodine receptors to combat aberrant levels of calcium release in neuronal cells. With a proven track record of innovation, Dahl's work addresses critical aspects of neurological disorders like Alzheimer's disease, Parkinson's disease, and many others.
Latest Patents: Dahl's recent patents showcase his expertise in developing compounds for stabilizing ryanodine receptors to address neuronal calcium dyshomeostasis. His noteworthy inventions include formulas capable of normalizing calcium levels in the brain, offering potential treatments for a wide range of disorders such as Alzheimer's, Parkinson's, and even aging-related CNS conditions.
Career Highlights: Russell Dahl is affiliated with the prestigious Rosalind Franklin University of Medicine and Science, where he continues to push the boundaries of neuroscientific research. His dedication to finding novel solutions for complex neurological conditions has garnered recognition within the scientific community.
Collaborations: Dahl collaborates with esteemed colleagues like Grace E Stutzmann and Christopher H Kaiho, further enhancing the impact of his work. Together, they strive to develop innovative therapies that could revolutionize the treatment of various neurological disorders, providing hope for millions around the globe.
Conclusion: In conclusion, Russell Dahl's pioneering work in the field of stabilizing ryanodine receptors demonstrates his commitment to advancing neuroscience and improving the lives of those affected by neurological conditions. With a focus on innovation and collaboration, Dahl's contributions have the potential to shape the future of neurology and bring relief to patients worldwide.
I hope you find this article informative and engaging. If you need any further assistance or details, feel free to let me know!
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile